We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+5.33%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.83B
AUM Growth
+$233M
Cap. Flow
+$131M
Cap. Flow %
4.64%
Top 10 Hldgs %
38.82%
Holding
108
New
54
Increased
16
Reduced
13
Closed
25

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$123M
2
INCY icon
Incyte
INCY
+$96M
3
EHC icon
Encompass Health
EHC
+$82.4M
4
WOOF icon
Petco
WOOF
+$73.5M
5
ZTS icon
Zoetis
ZTS
+$66.8M

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$100M
2
COO icon
Cooper Companies
COO
+$88.2M
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$86.9M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$81.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$80.5M

Sector Composition

Rank Sector Weight
1 Healthcare 83.85%
2 Real Estate 4.52%
3 Consumer Discretionary 2.42%
4 Financials 1.56%
5 Technology 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
51
Aurinia Pharmaceuticals
AUPH
$2.11B
$12.3M 0.44%
950,000
-5,987,448
-86% -$86.9M
ARYD
52
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$12.1M 0.43%
+1,159,360
New +$12.5M
CRIS icon
53
Curis
CRIS
$7.83M
$11.1M 0.39%
2,445
-3,491
-59% -$14.6M
CYTK icon
54
Cytokinetics
CYTK
$10.4B
$10.8M 0.38%
+462,500
New +$9.88M
RACB
55
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$10.3M 0.36%
+1,000,000
New +$10.2M
IMA
56
ImageneBio Inc
IMA
$64.6M
$9.64M 0.34%
+28,434
New +$9.74M
ICUI icon
57
ICU Medical
ICUI
$4.61B
$9.03M 0.32%
+43,960
New +$9.28M
IDXX icon
58
Idexx Laboratories
IDXX
$46.2B
$9.01M 0.32%
+18,410
New +$9.22M
INNV icon
59
InnovAge Holding
INNV
$1.52B
$8.38M 0.3%
+325,000
New +$8.01M
IRWD icon
60
Ironwood Pharmaceuticals
IRWD
$714M
$8.23M 0.29%
+736,201
New +$7.78M
MSACU
61
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
$7.78M 0.28%
+790,000
New +$8.03M
OHPAU
62
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$5.83M 0.21%
+582,920
New +$5.84M
CERN
63
DELISTED
Cerner Corp
CERN
$5.35M 0.19%
+74,420
New +$5.59M
CLDX icon
64
CALL
Celldex Therapeutics
CLDX
$3.28B
$5.25M 0.19%
+255,000
New +$5.86M
TIL icon
65
Instil Bio
TIL
$50.3M
$5.02M 0.18%
+10,000
New +$5.13M
OMEG
66
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$3.71M 0.13%
+375,000
New +$3.89M
PRDS
67
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.49M 0.12%
+350,000
New +$3.62M
ABGI
68
DELISTED
ABG Acquisition Corp. I
ABGI
$3.46M 0.12%
+350,000
New +$3.52M
EUCRU
69
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$3.36M 0.12%
+334,180
New +$3.56M
SRSAU
70
DELISTED
Sarissa Capital Acquisition Corp. Unit
SRSAU
$2.84M 0.1%
+262,150
New +$2.91M
LKFT
71
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$2.64M 0.09%
+34,260
New +$3.16M
FNCH
72
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2.42M 0.09%
+5,000
New +$2.55M
CMIIU
73
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$2.22M 0.08%
+173,563
New +$2.18M
JNCE
74
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.08M 0.07%
+202,585
New +$2.22M
JYAC
75
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$1.38M 0.05%
+140,680
New +$1.45M
1 2
3
4 5

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2021 Portfolio in Review

As of Q1 2021, HealthCor Management held 108 positions worth $2.83B, up 9% from $2.59B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

HealthCor Management deployed $131M of net new capital in Q1 2021, opening 54 new positions and adding to 16 existing holdings. Its largest new stake was Danaher: 604,236 shares worth $121M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 92% a quarter earlier, followed by Real Estate and Consumer Discretionary.

On the sell side, the largest reduction was Cooper Companies, an estimated $88.2M trimmed.

  • HealthCor Management's largest Q1 2021 buy was Danaher: 604,236 shares worth $121M.
  • HealthCor Management added most to Incyte in Q1 2021, an estimated $96M increase.
  • HealthCor Management's biggest Q1 2021 reduction was Cooper Companies, cutting an estimated $88.2M.
  • HealthCor Management fully exited Madrigal Pharmaceuticals in Q1 2021, selling an estimated $100M.
  • HealthCor Management's ten largest holdings make up 39% of its $2.83B portfolio in Q1 2021.
  • HealthCor Management opened 54 new positions and closed 25 in Q1 2021.
  • HealthCor Management's portfolio value rose 9% quarter-over-quarter to $2.83B.

Based on HealthCor Management's 13F filing for Q1 2021, filed 17 May 2021.